COMMUNIQUÉS West-GlobeNewswire

-
Ascendis Pharma Announces Once-weekly TransCon™ Growth Hormone Demonstrated Superiority on Primary Endpoint Compared to a Daily Growth Hormone in Phase 3 heiGHt Trial for Pediatric Growth Hormone Deficiency
04/03/2019 -
Orion Corporation: Managers' transactions - Virve Laitinen
04/03/2019 -
Orion Corporation: Managers' transactions - Jari Karlson
04/03/2019 -
Orion Corporation: Managers' transactions - Olli Huotari
04/03/2019 -
Orion Corporation: Managers' transactions - Christer Nordstedt
04/03/2019 -
Orion Corporation: Managers' transactions - Liisa Hurme
04/03/2019 -
Orion Corporation: Managers' transactions - Markku Huhta-Koivisto
04/03/2019 -
Orion Corporation: Managers' transactions - Satu Ahomäki
04/03/2019 -
Orion Corporation: Managers' transactions - Timo Lappalainen
04/03/2019 -
Orion Group Financial Statement documents 2018 and Corporate Governance Statement published
04/03/2019 -
Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2018 Financial Results
04/03/2019 -
Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
04/03/2019 -
Tecan schedules Analyst and Media Conference on March 11 to discuss Full-Year 2018 Financial Results
04/03/2019 -
Oasmia has completed a directed share issue of approximately 165 MSEK
04/03/2019 -
Nexstim Plc Publishes 2018 Annual Report
04/03/2019 -
NEXSTIM PLC FINANCIAL STATEMENTS RELEASE 2018
04/03/2019 -
Ossur Hf : Candidates to the Board of Directors
04/03/2019 -
Nightstar Therapeutics plc reaches agreement to be acquired by Biogen
04/03/2019 -
Biogen Announces Agreement to Acquire Nightstar Therapeutics to Establish Clinical Pipeline of Gene Therapy Candidates in Ophthalmology
04/03/2019
Pages